Fosaprepitant
Category: Nausea & VomitingFosaprepitant (Emend for Injection (US), Ivemend (EU)) is an antiemetic medication, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved by the U.S. Food and Drug Administration (FDA) on January 25, 2008,[1] and by the European Medicines Agency (EMA) on January 11 of the same year.[2] References .mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser... [wikipedia]
Dosage List
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0338-0008
Labeler:
Baxter Healthcare Corporation
Fosaprepitant 150 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0591-4385
Labeler:
Actavis Pharma, Inc.
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0781-3497
Labeler:
Sandoz Inc.
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 16714-120
Labeler:
Northstar Rxllc
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 16714-248
Labeler:
Northstar Rxllc
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 16714-929
Labeler:
Northstar Rxllc
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 16729-240
Labeler:
Accord Healthcare Inc.
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 25021-784
Labeler:
Sagent Pharmaceuticals
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 31722-165
Labeler:
Camber Pharmaceuticals, Inc.
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 43598-859
Labeler:
Dr. Reddy's Laboratories Inc.,
